Pasar al contenido principal

DAÑO ENDOGENO DEL DNA EN LA ANEMIA DE FANCONI

RTI2018-100692-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Metallo-liposomes of ruthenium used as promising vectors of genetic material

  • Lebrón, José Antonio
  • Ostos, Francisco José
  • López-López, Manuel
  • Moyá, María Luisa
  • Sales, Carlos
  • García, Encarnación
  • García-Calderón, Clara B.
  • García-Calderón, Margarita
  • Peña-Gómez, María José
  • Rosado, Iván V.
  • Balestra, Fernando R.
  • Huertas Sánchez, Pablo
  • López-Cornejo, Pilar
Gene therapy is a therapeutic process consisting of the transport of genetic material into cells. The design and preparation of novel carriers to transport DNA is an important research line in the medical field. Hybrid compounds such as metallo-liposomes, containing a mixture of lipids, were prepared and characterized. Cationic metal lipids derived from the [Ru(bpy)3]2+ complex, RuC11C11 or RuC19C19, both with different hydrophobic/lipophilic ratios, were mixed with the phospholipid DOPE. A relation between the size and the molar fraction α was found and a multidisciplinary study about the interaction between the metallo-liposomes and DNA was performed. The metallo-liposomes/DNA association was quantified and a relationship between Kapp and α was obtained. Techniques such as AFM, SEM, zeta potential, dynamic light scattering and agarose gel electrophoresis demonstrated the formation of lipoplexes and showed the structure of the liposomes. L/D values corresponding to the polynucleotide’s condensation were estimated. In vitro assays proved the low cell toxicity of the metallo-liposomes, lower for normal cells than for cancer cell lines, and a good internalization into cells. The latter as well as the transfection measurements carried out with plasmid DNA pEGFP-C1 have demonstrated a good availability of the Ru(II)-based liposomes for being used as non-toxic nanovectors in gene therapy., This work was funded by the Consejería de Educación y Ciencia de la Junta de Andalucía (Proyecto de Excelencia P12-FQM-1105, FQM-206 and FQM-274, and PI-0005-2018), the VI Plan Propio Universidad de Sevilla (PP2018-10338), the Ministerio de Ciencia, Innovación y Universidades (RTI2018-100692-B-I00), the grant Ramon y Cajal RYC2015-1867 and the European Union (Feder Funds)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Self-aggregation in aqueous solution of amphiphilic cationic calix[4]arenes. Potential use as vectors and nanocarriers

  • Ostos, Francisco José
  • Lebrón, José Antonio
  • López-Cornejo, Pilar
  • López-López, Manuel
  • García-Calderón, Margarita
  • García-Calderón, Clara B.
  • Rosado, Iván V.
  • Kalchenko, Vitaly I.
  • Rodik, Roman V.
  • Moyá, María Luisa
The self-aggregation of four amphiphilic cationic calix[4]arenes, CALIX, in aqueous solutions was investigated in this work. The nature of the polar group present at the upper rim as well as the length of the hydrophobic tails attached to the lower rim was varied. All the calixarenes present two critical aggregation concentrations, CAC1 and CAC2. For [CALIX] < CAC1 only micelles are present, within the range CAC1 < [CALIX] < CAC2 micelles as well as vesicles are observed, and for [CALIX] > CAC2 micelles and a wide distribution of vesicles were found. Cell viability experiments show that calixarene micelles and several of the calixarene vesicles investigated could be used as biocompatible nanocarriers. On this basis, the study of the interactions between the cationic calixarene aggregates (micelles and vesicles) and calf thymus DNA, ctDNA, were done and the results indicated that most of them strongly interact with the polynucleotide, inverting its charge. Micelles totally compact the ctDNA, while vesicles only partially cause conformational changes in the nucleic acid. Therefore, the CALIX micelles show potential as vectors in gene therapy. The encapsulation of the antineoplastic drug doxorubicin into the calixarene aggregates was also investigated. A high encapsulation efficiency was found for micelles and, specially, for vesicles. However, DOX-loaded calixarene vesicles present low stability at 37 °C, which is a serious restriction in their use as nanocarriers for this drug. The release of DOX from the calixarene micelles shows that they could lengthen the half-life of free doxorubicin in the body and, as a result, lower amounts of drug could be used in the cancer treatments diminishing the important side effects of DOX., This work was supported by the Consejería de Educación y Ciencia de la Junta de Andalucía (P12-FQM-1105, FQM-206 and FQM-274, and PI-0005-2018), the VI Plan Propio Universidad de Sevilla (PP2018-10338), the Ministerio de Ciencia, Innovación y Universidades (RTI2018-100692-B-I00), the grant Ramon y Cajal RYC2015-1867 and the European Union (Feder Funds). The authors thank the University of Seville for the grant VPPI-US.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Metallo-Liposomes Derived from the [Ru(bpy)3]2+ Complex as Nanocarriers of Therapeutic Agents

  • Moyá, María Luisa
  • Ostos, Francisco José
  • Moreno, Izamar
  • García, Diandra
  • Moreno-Gordillo, Paula
  • Rosado, Iván V.
  • López-Cornejo, Pilar
  • Lebrón, José Antonio
  • López-López, Manuel
This article belongs to the Special Issue The Application of Nanocarriers in Therapeutic Agents., The obtaining of nanocarriers of gene material and small drugs is still an interesting research line. Side-effects produced by the toxicity of several pharmaceutics, the high concentrations needed to get therapeutic effects, or their excessive use by patients have motivated the search for new nanostructures. For these reasons, cationic metallo-liposomes composed by phosphatidylcholine (PC), cholesterol (CHO) and RuC1C19 (a surfactant derived from the metallic complex [Ru(bpy)3]2+) were prepared and characterized by using diverse techniques (zeta potential, dynamic light scattering and electronic transmission microscopy –TEM-). Unimodal or bimodal populations of spherical aggregates with small sizes were obtained depending on the composition of the liposomes. The presence of cholesterol favored the formation of small aggregates. ct-DNA was condensed in the presence of the liposomes investigated. In-vitro assays demonstrated the ability of these nanoaggregates to internalize into different cell lines. A positive gene transfection into human bone osteosarcoma epithelial cells (U2OS) was also observed. The RuC1C19 surfactant was used as sensor to quantify the binding of DNA to the liposomes. Doxorubicin was encapsulated into the metallo-liposomes, demonstrating their ability to be also used as nanocarriers of drugs. A relationship between then encapsulation percentage of the antibiotic and the composition of the aggregates has been established., This research was funded by the Ayudas a Consolidación de Grupos de la Junta de Andalucía (2019/FQM-206 and 2019/FQM-274) and the European Union (FEDER Funds). IVR’s lab is recipient of a Ramón y Cajal Contract RYC2015-18670, and supported by grants RTI2018-100692-B-I00, PI-0005-2018 and P18-RT-1271.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

FANCD2 maintains replication fork stability during misincorporation of the DNA demethylation products 5-hydroxymethyl-2’-deoxycytidine and 5-hydroxymethyl-2’-deoxyuridine

  • Peña-Gómez, María José
  • Moreno-Gordillo, Paula
  • Narmontė, Milda
  • García-Calderón, Clara B.
  • Rukšėnaitė, Audronè
  • Klimašauskas, Saulius
  • Rosado, Iván V.
Fanconi anemia (FA) is a rare hereditary disorder caused by mutations in any one of the FANC genes. FA cells are mainly characterized by extreme hypersensitivity to interstrand crosslink (ICL) agents. Additionally, the FA proteins play a crucial role in concert with homologous recombination (HR) factors to protect stalled replication forks. Here, we report that the 5-methyl-2’-deoxycytidine (5mdC) demethylation (pathway) intermediate 5-hydroxymethyl-2’-deoxycytidine (5hmdC) and its deamination product 5-hydroxymethyl-2’-deoxyuridine (5hmdU) elicit a DNA damage response, chromosome aberrations, replication fork impairment and cell viability loss in the absence of FANCD2. Interestingly, replication fork instability by 5hmdC or 5hmdU was associated to the presence of Poly(ADP-ribose) polymerase 1 (PARP1) on chromatin, being both phenotypes exacerbated by olaparib treatment. Remarkably, Parp1 cells did not show any replication fork defects or sensitivity to 5hmdC or 5hmdU, suggesting that retained PARP1 at base excision repair (BER) intermediates accounts for the observed replication fork defects upon 5hmdC or 5hmdU incorporation in the absence of FANCD2. We therefore conclude that 5hmdC is deaminated in vivo to 5hmdU, whose fixation by PARP1 during BER, hinders replication fork progression and contributes to genomic instability in FA cells., The eHAP cell line were a generous gift from Dr. G. Crossan (MRC-LMB, Cambridge). DT40, NV012 and HSC72 cell lines were kindly provided by K.J. Patel (MRC WIMM, Oxford), and the MDA-MB-231, MDA-MB-436 and DLD1 BRCA2−/− were a gift from Dr. Pablo Huertas and Dr. Andrés Aguilera (CABIMER, Sevilla) respectively. We are in debt to Dr. J.A. Pérez-Simón (IBIS, Seville) for providing hosting and helpful advice. IVR´s lab is funded by MCIN/AEI/ 10.13039/501100011033, grant 18.06.03.3073 (RTI2018-100692-B-100), Consejerías de Salud, y de Economía y Conocimiento de la Junta de Andalucía, grants number PI-0005-2018, and 18.06.03.2404 (P18-RT-1271), Universidad de Sevilla “Programa Operativo FEDER Andalucía 2014–2020”, grant number 18.06.03.2319 (US-1381081), and by “ERDF A way of making Europe”. IVR is a recipient of Ramón y Cajal Contracts RYC2015-18670. SK lab was supported by ERC-2016-AdG/742654 grant.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

XRCC1 Prevents Replication Fork Instability during Misincorporation of the DNA Demethylation Bases 5-Hydroxymethyl-2′-Deoxycytidine and 5-Hydroxymethyl-2′-Deoxyuridine

  • Peña-Gómez, María José
  • Suárez-Pizarro, Marina
  • Rosado, Iván V.
Whilst avoidance of chemical modifications of DNA bases is essential to maintain genome stability, during evolution eukaryotic cells have evolved a chemically reversible modification of the cytosine base. These dynamic methylation and demethylation reactions on carbon-5 of cytosine regulate several cellular and developmental processes such as embryonic stem cell pluripotency, cell identity, differentiation or tumourgenesis. Whereas these physiological processes are well charac-terized, very little is known about the toxicity of these cytosine analogues when they incorporate during replication. Here, we report a role of the base excision repair factor XRCC1 in protecting replication fork upon incorporation of 5-hydroxymethyl-2-deoxycytosine (5hmC) and its deamination product 5-hydroxymethyl-2-deoxyuridine (5hmU) during DNA synthesis. In the absence of XRCC1, 5hmC exposure leads to increased genomic instability, replication fork impairment and cell lethality. Moreover, the 5hmC deamination product 5hmU recapitulated the genomic instability phenotypes observed by 5hmC exposure, suggesting that 5hmU accounts for the observed by 5hmC exposure. Remarkably, 5hmC-dependent genomic instability and replication fork impairment seen in Xrcc1 cells were exacerbated by the trapping of Parp1 on chromatin, indicating that XRCC1 maintains replication fork stability during processing of 5hmC and 5hmU by the base excision repair pathway. Our findings uncover natural epigenetic DNA bases 5hmC and 5hmU as genotoxic nucleosides that threaten replication dynamics and genome integrity in the absence of XRCC1., Grant 18.06.03.3073 RTI2018-100692-B-100 funded by MCIN/AEI/ 10.13039/501100011033 and, by “ERDF A way of making Europe”, Consejerías de Salud, y de Economía y Conocimiento, de la Junta de Andalucía, grants numbers PI-0005-2018, and P18-RT-1271, and Universidad de Sevilla “Programa Operativo FEDER Andalucía 2014-2020”, grant number US-1381081. I.V.R. is recipient of Ramón y Cajal Contract RYC2015-18670. M.S.-P. is a recipient of a JAEIntro fellowship JAEINT21_EX_0449. The APC was funded by RTI2018-100692-B-I00.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fluorescent Calixarene-Schiff as a Nanovehicle with Biomedical Purposes

  • Lebrón, José Antonio
  • López-López, Manuel
  • Moyá, María Luisa
  • Deasy, Mary
  • Muñoz-Wic, Ana
  • García-Calderón, Clara B.
  • Valle Rosado, Iván
  • López-Cornejo, Pilar
  • Bernal, Eva
  • Ostos, Francisco José
Gene therapy is a technique that is currently under expansion and development. Recent advances in genetic medicine have paved the way for a broader range of therapies and laid the groundwork for next-generation technologies. A terminally substituted difluorene-diester Schiff Base calix[4]arene has been studied in this work as possible nanovector to be used in gene therapy. Changes to luminescent behavior of the calixarene macrocycle are reported in the presence of ct-DNA. The calixarene macrocycle interacts with calf thymus DNA (ct-DNA), generating changes in its conformation. Partial double-strand denaturation is induced at low concentrations of the calixarene, resulting in compaction of the ct-DNA. However, interaction between calixarene molecules themselves takes place at high calixarene concentrations, favoring the decompaction of the polynucleotide. Based on cytotoxicity studies, the calixarene macrocycle investigated has the potential to be used as a nanovehicle and improve the therapeutic efficacy of pharmacological agents against tumors., This work was financed by the Consejería de Conocimiento, Innovación y Universidades de la Junta de Andalucía (FQM-206, FQM-274, and PY20-01234), the VI Plan Propio Universidad de Sevilla (PP2019/00000748), RTI2018-100692-B-100; P18-RT-1271; PI18-0005-2018; VI-PP AY.SUPLEM-2019; RYC-2015-18670 and the European Union (Feder Funds). F.J.O. thanks the University of Seville for the grant VPPI-US (DOC_00963)., Peer reviewed